Dr. Anthony M. Villano
- Surgical Oncologist
- Peritoneal Specialist
- Expertise:
-
Robotic Surgery
- Speciality:
-
Surgical Oncology
- Gender:
-
Male
- Language:
-
English
- Doctors At This Location
-
Dr. Sameera S. KumarAssistant Professor at Fox Chase Cancer CenterDr. Stephanie H. GrecoSurgical OncologistDr. Stacey SuThoracic SurgeonDr. Hossein BorghaeiOncologistDr. Gregory LubinieckiMedical OncologistDr. Joseph TreatMedical Oncologist
- Expertise:
-
Robotic Surgery
- Speciality:
-
Surgical Oncology
- Gender:
-
Male
- Language:
-
English
About Dr. Villano
Dr. Villano leads surgical oncology at Fox Chase Cancer Center and focuses on minimally invasive treatments for mesothelioma and other complex cancers of the abdomen, including soft tissue sarcomas. He treats every person with care and respect, creating an environment where patients feel supported and informed. Dr. Villano says, “I want every patient to leave the office confident knowing they have an entire team supporting them throughout their care and that they are active participants in how they are treated.”
Medical Education & Expertise
- Fox Chase Cancer Center, Assistant Professor of Surgical Oncology
- Fox Chase Cancer Center, Complex General Surgical Oncology (Fellowship)
- Medstar Georgetown University Hospital (Residency)
- Memorial Sloan Kettering Cancer Center (Fellowship)
- Rutgers Robert Wood Johnson Medical School (M.D.)
- Muhlenberg College, Biology (B.S.)
Associations, Awards & Recognition
- American College of Surgeons Leadership Conference and Advocacy Summit Scholarship, 2020
- Best Basic Science Research Award, Hufnagel Research Symposium, Medstar Georgetown University Hospital, 2016
- Best Clinical Research Award, DC Chapter of the American College of Surgeons, 2020
- Best Clinical Research Award, Hufnagel Research Symposium, Medstar Georgetown University Hospital, 2020
- Fox Chase Cancer Center Young Investigator’s Award, 2021
- John Ridge Fellowship Award 2022
- Medstar Georgetown Excellence in Resident Teaching Award, 2014
- Member, Alpha Omega Alpha Honors Society
- Member, American College of Surgeons
- Member, Americas Hepato-Pancreato-Biliary Association
- Member, Association for Academic Surgery
- Member, International Hepato-Pancreato-Biliary Association
- Member, Metro Philadelphia Chapter American College of Surgeons
- Member, Society for Surgery of the Alimentary Tract
- Member, Society of Surgical Oncology
- Member, Washington DC Chapter American College of Surgeons, 2013 – 2020
- Metropolitan Philadelphia Chapter ACS Poster Competition Awardee, 2021
- Top Doctor 2024, Philadelphia Magazine
Why Choose Dr. Villano for Mesothelioma?
Dr. Villano uses advanced surgical techniques to treat mesothelioma with the goal of minimizing pain and speeding recovery. He values clear communication and works closely with each person to explain their options and tailor care. His strong surgical skills and research experience in rare abdominal cancers make him a trusted mesothelioma specialist.
At Fox Chase Cancer Center, Dr. Villano collaborates with expert teams to offer personalized treatments for mesothelioma. He remains active in research to improve outcomes and develop new therapies, ensuring patients benefit from the latest advances in care.
Publications of Dr. Villano
- Villano, A. et al. (2022, September). Total neoadjuvant therapy is associated with improved overall survival and pathologic response in pancreatic adenocarcinoma. Retrieved from https://onlinelibrary.wiley.com/doi/10.1002/jso.26906
- Villano, A. et al. (2022, June). Total neoadjuvant therapy for pancreatic adenocarcinoma increases probability for a complete pathologic response. Retrieved from https://linkinghub.elsevier.com/retrieve/pii/S0748798321014451
- Villano, A. et al. (2022, April). National Trends in Treatment for Retroperitoneal Soft Tissue Sarcoma: A Modern Appraisal of Variability in Therapeutic Strategies. Retrieved from https://link.springer.com/article/10.1245/s10434-021-10908-z
- Villano, A. et al. (2020, November). Radical excision for retroperitoneal soft tissue sarcoma: A national propensity-matched outcomes analysis. Retrieved from https://linkinghub.elsevier.com/retrieve/pii/S0039606020303305
- Villano, A. et al. (2019, November). Minimally Invasive Surgery for Colorectal Cancer: Hospital Type Drives Utilization and Outcomes. Retrieved from https://www.researchgate.net/publication/337359343_Minimally_Invasive_Surgery_for_Colorectal_Cancer_Hospital_Type_Drives_Utilization_and_Outcomes